BIA
AMPH icon

Bell Investment Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bell Investment Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16
Closed -$427 – 1810
2025
Q3 		$427 Buy
+16
New +$413 ﹤0.01% 1807
2025
Q2 		– Sell
-15
Closed -$435 – 1885
2025
Q1 		$435 Sell
15
-12
-44% -$383 ﹤0.01% 1801
2024
Q4 		$1K Sell
27
-10
-27% -$457 ﹤0.01% 1581
2024
Q3 		$1.8K Buy
37
+10
+37% +$439 ﹤0.01% 1393
2024
Q2 		$1.08K Buy
27
+12
+80% +$497 ﹤0.01% 1596
2024
Q1 		$659 Hold
15
– – ﹤0.01% 1726
2023
Q4 		$928 Hold
15
– – ﹤0.01% 1617
2023
Q3 		$690 Sell
15
-11
-42% -$600 ﹤0.01% 1671
2023
Q2 		$1.5K Buy
26
+11
+73% +$488 ﹤0.01% 1437
2023
Q1 		$563 Buy
+15
New +$492 ﹤0.01% 1770
2022
Q3 		– Sell
-16
Closed -$1K – 1710
2022
Q2 		$1K Buy
+16
New +$571 ﹤0.01% 1314

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bell Investment Advisors's AMPH Position: Q4 2025 in Review

Bell Investment Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2025, closing a stake of 16 shares — an estimated $427 sold.

Bell Investment Advisors first reported a position in AMPH in Q2 2022 and held it in 11 quarters. The position peaked at $1.8K in Q3 2024. 235 funds tracked by Wall St. Rank hold AMPH as of Q4 2025.

  • Bell Investment Advisors reported no remaining Amphastar Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 16 Amphastar Pharmaceuticals shares in Q4 2025, an estimated $427.
  • Bell Investment Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • Bell Investment Advisors's Amphastar Pharmaceuticals position peaked at $1.8K in Q3 2024.
  • 235 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2025.

Based on Bell Investment Advisors's 13F filing for Q4 2025, filed 24 Feb 2026.